1. Bhugra D. The global prevalence of schizophrenia. PLoS Med 2005;2:e151PMID:
15916460.
2. Keshavan MS, Nasrallah HA, Tandon R. Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: From the elephant to the mouse. Schizophr Res 2011;127:3-13. PMID:
21316923.
3. Keshavan MS, Tandon R, Boutros NN, Nasrallah HA. Schizophrenia, "just the facts": what we know in 2008 Part 3: neurobiology. Schizophr Res 2008;106:89-107. PMID:
18799287.
4. van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS. Schizophrenia as a progressive brain disease. Eur Psychiatry 2008;23:245-254. PMID:
18513927.
5. Rish I, Cecchi G, Thyreau B, Thirion B, Plaze M, Paillere-Martinot ML, et al. Schizophrenia as a network disease: disruption of emergent brain function in patients with auditory hallucinations. PLoS One 2013;8:e50625PMID:
23349665.
6. Wu KY, Chao CW, Hung CI, Chen WH, Chen YT, Liang SF. Functional abnormalities in the cortical processing of sound complexity and musical consonance in schizophrenia: evidence from an evoked potential study. BMC Psychiatry 2013;13:158PMID:
23721126.
7. Näätänen R, Kähkönen S. Central auditory dysfunction in schizophrenia as revealed by the mismatch negativity (MMN) and its magnetic equivalent MMNm: a review. Int J Neuropsychopharmacol 2009;12:125-135. PMID:
18771603.
8. Iliadou VV, Apalla K, Kaprinis S, Nimatoudis I, Kaprinis G, Iacovides A. Is central auditory processing disorder present in psychosis? Am J Audiol 2013;22:201-208. PMID:
23824433.
9. Musiek F, Ballingham TM, Liu B, Paulovicks J, Swainson B, Tyler K, et al. Auditory hallucinations: an audiological perspective. Hear J 2007;60:32-52.
10. Rihs TA, Tomescu MI, Britz J, Rochas V, Custo A, Schneider M, et al. Altered auditory processing in frontal and left temporal cortex in 22q11.2 deletion syndrome: a group at high genetic risk for schizophrenia. Psychiatry Res 2013;212:141-149. PMID:
23137800.
11. Curcic-Blake B, Liemburg E, Vercammen A, Swart M, Knegtering H, Bruggeman R, et al. When Broca goes uninformed: reduced information flow to Broca's area in schizophrenia patients with auditory hallucinations. Schizophr Bull 2013;39:1087-1095. PMID:
23070537.
12. Hoffman RE, Pittman B, Constable RT, Bhagwagar Z, Hampson M. Time course of regional brain activity accompanying auditory verbal hallucinations in schizophrenia. Br J Psychiatry 2011;198:277-283. PMID:
21972276.
13. Simons CJ, Tracy DK, Sanghera KK, O'Daly O, Gilleen J, Dominguez MD, et al. Functional magnetic resonance imaging of inner speech in schizophrenia. Biol Psychiatry 2010;67:232-237. PMID:
19846064.
14. Kwon JS, McCarley RW, Hirayasu Y, Anderson JE, Fischer IA, Kikinis R, et al. Left planum temporale volume reduction in schizophrenia. Arch Gen Psychiatry 1999;56:142-148. PMID:
10025438.
15. Modinos G, Costafreda SG, van Tol MJ, McGuire PK, Aleman A, Allen P. Neuroanatomy of auditory verbal hallucinations in schizophrenia: a quantitative meta-analysis of voxel-based morphometry studies. Cortex 2013;49:1046-1055. PMID:
22370252.
16. O'Daly OG, Frangou S, Chitnis X, Shergill SS. Brain structural changes in schizophrenia patients with persistent hallucinations. Psychiatry Res 2007;156:15-21. PMID:
17720459.
17. Hugdahl K, Løberg EM, Nygård M. Left temporal lobe structural and functional abnormality underlying auditory hallucinations in schizophrenia. Front Neurosci 2009;3:34-45. PMID:
19753095.
18. Hugdahl K, Loberg EM, Jorgensen HA, Lundervold A, Lund A, Green MF, et al. Left hemisphere lateralisation of auditory hallucinations in schizophrenia: a dichotic listening study. Cogn Neuropsychiatry 2008;13:166-179. PMID:
18302028.
19. Källstrand J, Nehlstedt SF, Sköld ML, Nielzén S. Lateral asymmetry and reduced forward masking effect in early brainstem auditory evoked responses in schizophrenia. Psychiatry Res 2012;196:188-193. PMID:
22326876.
20. Nam EC. Is it necessary to differentiate tinnitus from auditory hallucination in schizophrenic patients? J Laryngol Otol 2005;119:352-355. PMID:
15949097.
21. Igata M, Ohta M, Hayashida Y, Abe K. Missing peaks in auditory brainstem responses and negative symptoms in schizophrenia. Jpn J Psychiatry Neurol 1994;48:571-578. PMID:
7891420.
22. Leavitt VM, Molholm S, Ritter W, Shpaner M, Foxe JJ. Auditory processing in schizophrenia during the middle latency period (10-50 ms): high-density electrical mapping and source analysis reveal subcortical antecedents to early cortical deficits. J Psychiatry Neurosci 2007;32:339-353. PMID:
17823650.
23. Pickles JO. The Centrifugal Pathways. In: Pickles JO, editor. An introduction to the physiology of hearing. 2nd Ed. London: Academic Press, 1988, p. 235-255.
24. Perrot X, Ryvlin P, Isnard J, Guénot M, Catenoix H, Fischer C, et al. Evidence for corticofugal modulation of peripheral auditory activity in humans. Cereb Cortex 2006;16:941-948. PMID:
16151174.
25. Aleman A, Bocker KB, Hijman R, de Haan EH, Kahn RS. Cognitive basis of hallucinations in schizophrenia: role of top-down information processing. Schizophr Res 2003;64:175-185. PMID:
14613682.
26. Mishra SK, Lutman ME. Top-down influences of the medial olivocochlear efferent system in speech perception in noise. PLoS One 2014;9:e85756PMID:
24465686.
27. Suga N. Tuning shifts of the auditory system by corticocortical and corticofugal projections and conditioning. Neurosci Biobehav Rev 2012;36:969-988. PMID:
22155273.
28. Leon A, Elgueda D, Silva MA, Hamame CM, Delano PH. Auditory cortex basal activity modulates cochlear responses in chinchillas. PLoS One 2012;7:e36203PMID:
22558383.
29. Veuillet E, Georgieff N, Philibert B, Dalery J, Marie-Cardine M, Collet L. Abnormal peripheral auditory asymmetry in schizophrenia. J Neurol Neurosurg Psychiatry 2001;70:88-94. PMID:
11118254.
30. De Ceulaer G, Yperman M, Daemers K, Van Driessche K, Somers T, Offeciers FE, et al. Contralateral suppression of transient evoked otoacoustic emissions: normative data for a clinical test set-up. Otol Neurotol 2001;22:350-355. PMID:
11347638.
31. Yalçınkaya F, Yılmaz ST, Muluk NB. Transient evoked otoacoustic emissions and contralateral suppressions in children with auditory listening problems. Auris Nasus Larynx 2010;37:47-54. PMID:
19411150.
32. Giraud AL, Collet L, Chéry-Croze S, Magnan J, Chays A. Evidence of a medial olivocochlear involvement in contralateral suppression of otoacoustic emissions in humans. Brain Res 1995;705:15-23. PMID:
8821728.
33. Stuart A, Butler AK. Contralateral suppression of transient otoacoustic emissions and sentence recognition in noise in young adults. J Am Acad Audiol 2012;23:686-696. PMID:
23072961.
34. Ugur AK, Kemaloglu YK, Ugur MB, Gunduz B, Saridogan C, Yesilkaya E, et al. Otoacoustic emissions and effects of contralateral white noise stimulation on transient evoked otoacoustic emissions in diabetic children. Int J Pediatr Otorhinolaryngol 2009;73:555-559. PMID:
19150138.
35. Giraud AL, Collet L, Chéry-Croze S. Suppression of otoacoustic emission is unchanged after several minutes of contralateral acoustic stimulation. Hear Res 1997;109:78-82. PMID:
9259237.
36. Prasher D, Ryan S, Luxon L. Contralateral suppression of transiently evoked otoacoustic emissions and neuro-otology. Br J Audiol 1994;28:247-254. PMID:
7735153.
37. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of Brief Psyciatric Rating Scales scores. Br J Psychiatry 2005;187:366-371. PMID:
16199797.
38. Wahab S, Zakaria MN, Sidek D, Abdul Rahman AH, Shah SA, Abdul Wahab NA. Evaluation of auditory hallucinations in patients with schizophrenia: a validation study of the Malay version of Psychotic Symptom Rating Scales (PSYRATS). Psychiatry Res 2015;228:462-467. PMID:
26142835.
39. Urnau D, Tochetto TM. Occurrence and suppression effect of otoacoustic emissions in normal hearing adults with tinnitus and hyperacusis. Braz J Otorhinolaryngol 2012;8:87-94. PMID:
22392244.
40. Abdollahi FZ, Lotfi Y. Gender difference in TEOAEs and contralateral suppression of TEOAEs in normal hearing adults. Iran Rehab J 2011;9:22-25.
41. Daskalakis ZJ, George TP. Clozapine, GABA(B), and the treatment of resistant schizophrenia. Clin Pharmacol Ther 2009;86:442-446. PMID:
19626000.
42. Farzan F, Barr MS, Levinson AJ, Chen R, Wong W, Fitzgerald PB, et al. Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia. Brain 2010;133(Pt 5):1505-1514. PMID:
20350936.
43. Wedemeyer C, Zorrilla de San Martín J, Ballestero J, Gómez-Casati ME, Torbidoni AV, Fuchs PA, et al. Activation of presynaptic GABA(B (1a,2)) receptors inhibits synaptic transmission at mammalian inhibitory cholinergic olivocochlear-hair cell synapses. J Neurosci 2013;33:15477-15487. PMID:
24068816.
44. Im GJ. Role of nicotinic acetylcholine receptor on efferent inhibition in cochlear hair cell. Korean J Audiol 2012;16:108-113. PMID:
24653883.
45. Källstrand J, Nehlstedt SF, Sköld ML, Nielzén S. Lateral asymmetry and reduced forward masking effect in early brainstem auditory evoked responses in schizophrenia. Psychiatry Res 2012;196:188-193. PMID:
22326876.
46. Collinson SL, Mackay CE, O J, James AC, Crow TJ. Dichotic listening impairments in early onset schizophrenia are associated with reduced left temporal lobe volume. Schizophr Res 2009;112:24-31. PMID:
19423299.
47. Ford JM, Mathalon DH. Corollary discharge dysfunction in schizophrenia: can it explain auditory hallucinations? Int J Psychophysiol 2005;58:179-189. PMID:
16137779.
48. Shergill SS, Brammer MJ, Williams SC, Murray RM, McGuire PK. Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch Gen Psychiatry 2000;57:1033-1038. PMID:
11074868.
49. Guinan JJ. Olivocochlear efferents: anatomy, physiology, function, and the measurement of efferent effects in humans. Ear Hear 2006;27:589-607. PMID:
17086072.
50. Geven LI, de Kleine E, Free RH, van Dijk P. Contralateral suppression of otoacoustic emissions in tinnitus patients. Otol Neurotol 2011;32:315-321. PMID:
20962699.
51. Stuart A, Preast JL. Contralateral suppression of transient-evoked otoacoustic emissions in children with sickle cell disease. Ear Hear 2012;33:421-429. PMID:
22246207.
52. O'Connor WT, O'Shea SD. Clozapine and GABA transmission in schizophrenia disease models: establishing principles to guide treatments. Pharmacol Ther 2015;150:47-80. PMID:
25585121.
53. Tayoshi S, Nakataki M, Sumitani S, Taniguchi K, Shibuya-Tayoshi S, Numata S, et al. GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study. Schizophr Res 2010;117:83-91. PMID:
20022731.
54. Goto N, Yoshimura R, Kakeda S, Moriya J, Hori H, Hayashi K, et al. No alterations of brain GABA after 6 months of treatment with atypical antipsychotic drugs in early-stage first-episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:1480-1483. PMID:
20727934.
55. Ichikawa J, Dai J, O'Laughlin IA, Fowler WL, Meltzer HY. Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 2002;26:325-339. PMID:
11850147.
56. Mandal A, Mishra S, Mandal P. Sex specific differences in GABA and glutamate levels in response to cigarette smoke. Sci Rep 2013;2:613-614.